Search clinical trials for: Elotuzumab (BMS-901608; HuLuc63)
Total 44 results
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
AbbottBristol-Myers SquibbTerminated
-
Bristol-Myers SquibbNo longer availableMultiple Myeloma
-
Facet BiotechCompletedMultiple MyelomaUnited States
-
Sundar JagannathBristol-Myers SquibbNo longer available
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
Bristol-Myers SquibbAbbVieCompleted
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbAbbVieCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbTerminatedMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieNo longer available
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaCanada, United States, Israel, Czechia, Switzerland, Greece, Denmark, Portugal, Italy, Germany, Austria, Norway, Puerto Rico, Spain, Sweden, Turkey
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
CelgeneNot yet recruitingMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
OncotherapeuticsTerminated
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
Bristol-Myers SquibbAbbVieCompletedRelapsed and/or Refractory Multiple MyelomaSpain
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Italy, Spain, France, Canada
-
AbbVie (prior sponsor, Abbott)Bristol-Myers SquibbCompleted
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Rho Federal Systems Division, Inc.; Autoimmunity Centers...TerminatedIgG4 Related Disease | IgG4-RDUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
Bristol-Myers SquibbAbbottTerminatedNewly Diagnosed, Previously Untreated Multiple MyelomaUnited States, Poland, Italy, Greece
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Abdullah KhanRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingLymphoma | Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Lymphocytic NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell NeoplasmUnited States
-
Mayo ClinicNational Cancer Institute (NCI)SuspendedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Breast Carcinoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic LymphomaUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedB Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Acute Lymphoblastic Leukemia in RemissionUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute LeukemiaUnited States, Canada, Australia, Puerto Rico, New Zealand